COVID-19 (severe/critical) |
Laboratory Findings |
Lymphocytes [1 unit decrease vs. Normal] |
Odds ratio: 1.380 (0.190-10.160)
§ |
Wei
|
|
|
COVID-19 (severe/critical) |
Symptoms |
Fingertip oxygen saturation [1% decrease vs. Normal] |
Odds ratio: 0.550 (0.390-0.760)
§ |
Wei
|
|
|
COVID-19 (severe/critical) |
Symptoms |
Shortness of breath [Present vs. Not present] |
Odds ratio: 2.040 (0.600-6.910)
§ |
Wei
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Diabetes [Present vs. Not present] |
Odds ratio: 0.730 (0.060-8.340)
§ |
Wei
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Any comorbidity [Present vs. Not present] |
Odds ratio: 2.770 (0.760-10.060)
§ |
Wei
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Age [1 year increase vs. Not applicable] |
Odds ratio: 1.000 (0.960-1.050)
§ |
Wei
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
Lymphocytes [Abnormal vs. Normal] |
Odds ratio: 0.100 (0.020-0.480)
§ |
Liu
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
Neutrophils [1 unit increase vs. Normal] |
Odds ratio: 1.090 (0.760-1.580)
§ |
Liu
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
CRP [Abnormal vs. Normal] |
Odds ratio: 1.380 (1.080-1.770)
§ |
Liu
|
|
|
COVID-19 (severe/critical) |
Symptoms |
Anorexia/lethargy [Present vs. Not present] |
Odds ratio: 2.590 (0.710-9.450)
§ |
Liu
|
|
|
COVID-19 (severe/critical) |
Symptoms |
Fatigue [Present vs. Not present] |
Odds ratio: 3.740 (0.980-14.300)
§ |
Liu
|
|
|
COVID-19 (severe/critical) |
Symptoms |
Dyspnea [Present vs. Not present] |
Odds ratio: 1.480 (0.390-5.550)
§ |
Liu
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Hypertension [Present vs. Not present] |
Odds ratio: 3.590 (1.010-12.800)
§ |
Liu
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Age [1 year increase vs. Not applicable] |
Odds ratio: 1.830 (0.520-6.410)
§ |
Liu
|
|
|
COVID-19 (severe/critical) |
Findings |
Radiological finding on admission [Consolidation on chest CT vs. Normal] |
Odds ratio: 12.200 (2.230-66.590)
|
Tabata
|
|
|
COVID-19 (severe/critical) |
Findings |
Radiological finding during hospitalization [Consolidation on chest CT vs. Normal] |
Odds ratio: 3.270 (1.150-9.300)
|
Tabata
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
LDH [Abnormal at admission vs. Normal] |
Odds ratio: 7.250 (1.430-36.700)
|
Tabata
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
Lymphopenia during hospitalization [Present vs. Not present] |
Odds ratio: 4.400 (1.570-12.320)
|
Tabata
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
Lymphopenia at hospital admission [Present vs. Not present] |
Odds ratio: 5.000 (1.100-22.920)
|
Tabata
|
|
|
COVID-19 (death) |
Treatment |
Treatment for COVID-19 [Umifenovir received vs. Not received] |
Hazard ratio: 0.540 (0.340-0.840)
§ |
Li
|
|
|
COVID-19 (death) |
Treatment |
Treatment for COVID-19 [Treated with Lopinavir–Ritonavir vs. Not received] |
Hazard ratio: 0.430 (0.210-0.890)
§ |
Li
|
|
|
COVID-19 (death) |
Treatment |
Concomitant medication [High dose corticosteroid vs. Not received] |
Hazard ratio: 3.500 (1.790-6.860)
§ |
Li
|
|
|
COVID-19 (death) |
Treatment |
Concomitant medication [Low dose corticosteroid vs. Not received] |
Hazard ratio: 1.260 (0.610-2.580)
§ |
Li
|
|
|
COVID-19 (death) |
Complications |
Hyperglycemia [Present vs. Not present] |
Hazard ratio: 1.770 (1.110-2.840)
§ |
Li
|
|
|
COVID-19 (death) |
Complications |
Cardiac injury [Present vs. Not present] |
Hazard ratio: 2.920 (1.800-4.760)
§ |
Li
|
|
|
COVID-19 (death) |
Laboratory Findings |
LDH [1 unit increase (at admission) vs. Not applicable] |
Hazard ratio: 2.000 (1.210-3.300)
§ |
Li
|
|
|
COVID-19 (death) |
Laboratory Findings |
Leukocyte [1 unit increase (at admission) vs. Not applicable] |
Hazard ratio: 2.040 (1.260-3.310)
§ |
Li
|
|
|
COVID-19 (death) |
Patient characteristics |
Age [>=65 years vs. <65 years] |
Hazard ratio: 1.720 (1.090-2.730)
§ |
Li
|
|
|
COVID-19 (death) |
Patient characteristics |
Gender [Male vs. Female] |
Hazard ratio: 1.720 (1.050-2.820)
§ |
Li
|
|
|
COVID-19 (severe/critical) |
Findings |
Liver test during hospitalization [Cholestatic vs. Normal] |
Odds ratio: 3.450 (1.250-9.500)
§ |
Cai
|
|
|
COVID-19 (severe/critical) |
Findings |
Liver test during hospitalization [Hepatocellular vs. Normal] |
Odds ratio: 3.830 (1.450-10.110)
§ |
Cai
|
|
|
COVID-19 (severe/critical) |
Findings |
Liver test during hospitalization [Mixed vs. Normal] |
Odds ratio: 11.220 (4.420-28.450)
§ |
Cai
|
|
|
COVID-19 (severe/critical) |
Findings |
Liver test during hospitalization [Cholestatic vs. Normal] |
Odds ratio: 1.090 (0.340-3.490)
§ |
Cai
|
|
|
COVID-19 (severe/critical) |
Findings |
Liver test during hospitalization [Hepatocellular vs. Normal] |
Odds ratio: 3.190 (1.150-8.840)
§ |
Cai
|
|
|
COVID-19 (severe/critical) |
Findings |
Liver test during hospitalization [Injury vs. Normal] |
Odds ratio: 9.040 (3.190-25.600)
§ |
Cai
|
|
|
COVID-19 (severe/critical) |
Findings |
Liver test during hospitalization [Abnormal vs. Normal] |
Odds ratio: 2.480 (0.940-6.550)
§ |
Cai
|
|
|
COVID-19 (severe/critical) |
Findings |
Liver test at hospital admission [Cholestatic vs. Normal] |
Odds ratio: 1.750 (0.840-3.640)
§ |
Cai
|
|
|
COVID-19 (severe/critical) |
Findings |
Liver test at hospital admission [Hepatocellular vs. Normal] |
Odds ratio: 1.640 (0.860-3.120)
§ |
Cai
|
|
|
COVID-19 (severe/critical) |
Findings |
Liver test at hospital admission [Mixed vs. Normal] |
Odds ratio: 4.440 (1.930-10.230)
§ |
Cai
|
|
|
COVID-19 (severe/critical) |
Findings |
Liver test at hospital admission [Cholestatic vs. Normal] |
Odds ratio: 1.280 (0.580-2.820)
§ |
Cai
|
|
|
COVID-19 (severe/critical) |
Findings |
Liver test at hospital admission [Hepatocellular vs. Normal] |
Odds ratio: 2.730 (1.190-6.300)
§ |
Cai
|
|
|
COVID-19 (severe/critical) |
Findings |
Liver test at hospital admission [Injury vs. Normal] |
Odds ratio: 2.030 (0.690-5.980)
§† |
Cai
|
|
|
COVID-19 (severe/critical) |
Findings |
Liver test at hospital admission [Abnormal vs. Normal] |
Odds ratio: 1.640 (0.910-2.950)
§ |
Cai
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
BMI [Severe obesity (>35kg/m2) vs. Normal (<25 kg/m2)] |
Odds ratio: 7.360 (1.630-33.140)
§ |
Simonnet
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
BMI [Obesity (30-35kg/m2) vs. Normal (<25 kg/m2)] |
Odds ratio: 3.450 (0.830-14.310)
§ |
Simonnet
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
BMI [Overweight (25-29kg/m2) vs. Normal (<25 kg/m2)] |
Odds ratio: 1.690 (0.520-5.480)
§ |
Simonnet
|
|
|
COVID-19 (severe/critical) |
Complications |
Dyslipidemia [Present vs. Not present] |
Odds ratio: 0.680 (0.240-1.970)
§ |
Simonnet
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Hypertension [Present vs. Not present] |
Odds ratio: 2.290 (0.890-5.840)
§ |
Simonnet
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Diabetes [Present vs. Not present] |
Odds ratio: 1.600 (0.440-5.830)
§ |
Simonnet
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Gender [Male vs. Female] |
Odds ratio: 2.830 (1.020-7.850)
§ |
Simonnet
|
|
|